SMO ClinPlus Overview
- Year Founded
-
2013
- Status
-
Public
- Employees
-
4,372
- Stock Symbol
-
301257
- Investments
-
2
- Share Price
-
$5.08
- (As of Friday Closing)
SMO ClinPlus General Information
Description
SMO Clinplus Co Ltd is engaged in providing SMO services to domestic and foreign pharmaceutical companies, medical device companies, and clinical research and development of some health-related products. The services provided include Preliminary model establishment, Preliminary plan preparation, Initiation of clinical trial sites, On-site implementation, and Comprehensive project management.
Contact Information
Website
www.smo-clinplus.comCorporate Office
- 23rd Floor, World Trade Building
- 500 Guangdong Road, Huangpu District
- Shanghai, 200001
- China
Corporate Office
- 23rd Floor, World Trade Building
- 500 Guangdong Road, Huangpu District
- Shanghai, 200001
- China
SMO ClinPlus Stock Performance
As of 13-Nov-2026, SMO ClinPlus’s stock price is $5.08. Its current market cap is $401M with 79M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.08 | $5.27 | $4.54 - $12.18 | $401M | 79M | 3.88M | $0.05 |
SMO ClinPlus Financials Summary
As of 30-Sep-2026, SMO ClinPlus has a trailing 12-month revenue of $119M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 417,791 | 496,717 | 174,499 | 421,969 |
| Revenue | 118,925 | 117,156 | 112,011 | 107,428 |
| EBITDA | 5,885 | 19,628 | 18,348 | 23,261 |
| Net Income | 4,302 | 15,246 | 14,832 | 19,043 |
| Total Assets | 226,589 | 220,664 | 195,836 | 192,819 |
| Total Debt | 324 | 617 | 900 | 1,563 |
SMO ClinPlus Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
SMO ClinPlus Signals
SMO ClinPlus Investments (2)
SMO ClinPlus’s most recent deal was a Later Stage VC with Oceanus Plus. The deal was made on 01-Apr-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Oceanus Plus | 01-Apr-2020 | Later Stage VC | Enterprise Systems (Healthcare) | ||
| Oceanus Plus | 27-Feb-2019 | Later Stage VC | Enterprise Systems (Healthcare) |
SMO ClinPlus ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Commercial Services
Industry
Rank
Percentile
Business Support Services
Subindustry
Rank
Percentile
SMO ClinPlus FAQs
-
When was SMO ClinPlus founded?
SMO ClinPlus was founded in 2013.
-
Where is SMO ClinPlus headquartered?
SMO ClinPlus is headquartered in Shanghai, China.
-
What is the size of SMO ClinPlus?
SMO ClinPlus has 4,372 total employees.
-
What industry is SMO ClinPlus in?
SMO ClinPlus’s primary industry is Laboratory Services (Healthcare).
-
Is SMO ClinPlus a private or public company?
SMO ClinPlus is a Public company.
-
What is SMO ClinPlus’s stock symbol?
The ticker symbol for SMO ClinPlus is 301257.
-
What is the current stock price of SMO ClinPlus?
As of 13-Nov-2026 the stock price of SMO ClinPlus is $5.08.
-
What is the current market cap of SMO ClinPlus?
The current market capitalization of SMO ClinPlus is $401M.
-
What is SMO ClinPlus’s current revenue?
The trailing twelve month revenue for SMO ClinPlus is $119M.
-
What is SMO ClinPlus’s annual earnings per share (EPS)?
SMO ClinPlus’s EPS for 12 months was $0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process